Cancer - IDEAYA Biosciences

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT05907954

(Neo) Adjuvant IDE196 (Darovasertib) in patients with localized ocular melanoma

Drug

IDE196

Condition

Ocular melanoma